Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

122 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cancer risks from germline p53 mutations.
Frebourg T, Friend SH. Frebourg T, et al. Among authors: friend sh. J Clin Invest. 1992 Nov;90(5):1637-41. doi: 10.1172/JCI116034. J Clin Invest. 1992. PMID: 1430194 Free PMC article. Review. No abstract available.
CANCER. The cancer predisposition revolution.
Malkin D, Garber JE, Strong LC, Friend SH. Malkin D, et al. Among authors: friend sh. Science. 2016 May 27;352(6289):1052-3. doi: 10.1126/science.aag0832. Science. 2016. PMID: 27230363 No abstract available.
Correction: a Li-Fraumeni syndrome p53 mutation.
Malkin D, Friend SH. Malkin D, et al. Among authors: friend sh. Science. 1993 Feb 12;259(5097):878. Science. 1993. PMID: 8438145 No abstract available.
Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity.
Shi LM, Myers TG, Fan Y, O'Connor PM, Paull KD, Friend SH, Weinstein JN. Shi LM, et al. Among authors: friend sh. Mol Pharmacol. 1998 Feb;53(2):241-51. doi: 10.1124/mol.53.2.241. Mol Pharmacol. 1998. PMID: 9463482
Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo.
Ishioka C, Englert C, Winge P, Yan YX, Engelstein M, Friend SH. Ishioka C, et al. Among authors: friend sh. Oncogene. 1995 Apr 20;10(8):1485-92. Oncogene. 1995. PMID: 7731702
An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.
Bae I, Smith ML, Sheikh MS, Zhan Q, Scudiero DA, Friend SH, O'Connor PM, Fornace AJ Jr. Bae I, et al. Among authors: friend sh. Cancer Res. 1996 Feb 15;56(4):840-7. Cancer Res. 1996. PMID: 8631022
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Børresen AL, Friend SH. Frebourg T, et al. Among authors: friend sh. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6413-7. doi: 10.1073/pnas.89.14.6413. Proc Natl Acad Sci U S A. 1992. PMID: 1631137 Free PMC article.
Genetic models for studying cancer susceptibility.
Friend SH. Friend SH. Science. 1993 Feb 5;259(5096):774-5. doi: 10.1126/science.8430329. Science. 1993. PMID: 8430329 No abstract available.
The importance of p53 gene alterations in human cancer: is there more than circumstantial evidence?
Frebourg T, Friend SH. Frebourg T, et al. Among authors: friend sh. J Natl Cancer Inst. 1993 Oct 6;85(19):1554-7. doi: 10.1093/jnci/85.19.1554. J Natl Cancer Inst. 1993. PMID: 8411229 Review. No abstract available.
Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype.
Frebourg T, Sadelain M, Ng YS, Kassel J, Friend SH. Frebourg T, et al. Among authors: friend sh. Cancer Res. 1994 Feb 15;54(4):878-81. Cancer Res. 1994. PMID: 8313374
122 results
Jump to page
Feedback